JP2014521647A5 - - Google Patents

Download PDF

Info

Publication number
JP2014521647A5
JP2014521647A5 JP2014522900A JP2014522900A JP2014521647A5 JP 2014521647 A5 JP2014521647 A5 JP 2014521647A5 JP 2014522900 A JP2014522900 A JP 2014522900A JP 2014522900 A JP2014522900 A JP 2014522900A JP 2014521647 A5 JP2014521647 A5 JP 2014521647A5
Authority
JP
Japan
Prior art keywords
imidazolidin
ylidene
amine
compound
quinolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014522900A
Other languages
English (en)
Japanese (ja)
Other versions
JP6031719B2 (ja
JP2014521647A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/047570 external-priority patent/WO2013016178A1/en
Publication of JP2014521647A publication Critical patent/JP2014521647A/ja
Publication of JP2014521647A5 publication Critical patent/JP2014521647A5/ja
Application granted granted Critical
Publication of JP6031719B2 publication Critical patent/JP6031719B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014522900A 2011-07-25 2012-07-20 アルファ2アドレナリン作動性受容体のモジュレーターとしてのn−(イミダゾリジン−2−イリデン)キノリン誘導体 Expired - Fee Related JP6031719B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161511298P 2011-07-25 2011-07-25
US61/511,298 2011-07-25
PCT/US2012/047570 WO2013016178A1 (en) 2011-07-25 2012-07-20 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors

Publications (3)

Publication Number Publication Date
JP2014521647A JP2014521647A (ja) 2014-08-28
JP2014521647A5 true JP2014521647A5 (https=) 2015-09-10
JP6031719B2 JP6031719B2 (ja) 2016-11-24

Family

ID=46582084

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014522900A Expired - Fee Related JP6031719B2 (ja) 2011-07-25 2012-07-20 アルファ2アドレナリン作動性受容体のモジュレーターとしてのn−(イミダゾリジン−2−イリデン)キノリン誘導体

Country Status (11)

Country Link
US (3) US8815861B2 (https=)
EP (1) EP2736902A1 (https=)
JP (1) JP6031719B2 (https=)
KR (1) KR20140062471A (https=)
CN (1) CN103827107A (https=)
AU (1) AU2012287164A1 (https=)
BR (1) BR112014001938A2 (https=)
CA (1) CA2843251A1 (https=)
HK (1) HK1198762A1 (https=)
RU (1) RU2014106364A (https=)
WO (1) WO2013016178A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8941159B2 (en) 2013-01-30 2015-01-27 Omnivision Technologies, Inc. Color filter including clear pixel and hard mask

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB889282A (en) 1957-05-07 1962-02-14 Air Reduction Preparation of hexafluorodiethyl ether and medicinal compositions containing it
BE795970A (fr) * 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
WO1995010280A1 (en) * 1993-10-13 1995-04-20 Allergan Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
SK77396A3 (en) * 1993-12-17 1997-01-08 Procter & Gamble 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists
HU217841B (hu) * 1993-12-17 2000-04-28 The Procter & Gamble Co. 6-[(2-Imidazolidinilidén)-amino]-kinolin-származékok és ezeket tartalmazó gyógyszerkészítmények
US5576437A (en) 1993-12-17 1996-11-19 The Procter & Gamble Company 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
EP0775134A4 (en) 1994-08-04 1997-08-13 Synaptic Pharma Corp NEW BENZIMIDAZOLE DERIVATIVES
AU715350B2 (en) * 1995-05-12 2000-01-20 Allergan, Inc. Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects
US6087361A (en) 1995-05-12 2000-07-11 Allergan Sales, Inc. Aryl-imidazolines and aryl-imidazoles useful as α-2 adrenergic agonists without cardiovascular side effects
US5677321A (en) 1996-02-29 1997-10-14 Synaptic Pharmaceutical Corporation 5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands
ES2756499T3 (es) * 2009-10-06 2020-04-27 Allergan Inc Derivados de 2H-pirrol-5-amina como moduladores de receptor alfa adrenérgico

Similar Documents

Publication Publication Date Title
KR101893632B1 (ko) 아레나바이러스 감염의 치료를 위한 항바이러스 약물
JP6795517B2 (ja) 5−芳香族アルキニル基置換ベンズアミド系化合物並びにその製造方法、薬物組成物及び使用
JP2016505637A5 (https=)
NZ610230A (en) Compositions and methods for treating ocular edema, neovascularization and related diseases
MX2012001504A (es) Compuestos antivirales y metodos para elaborarlos y usarlos.
JP2011042668A5 (https=)
JP2014502641A5 (https=)
CN107001806B (zh) 用于治疗心肺疾病的鞘氨醇-1-磷酸盐受体调节剂
EA201691058A1 (ru) Производные пирролопирролона и их применение для лечения заболеваний
JP2010536842A5 (https=)
RU2012134639A (ru) Фармацевтический препарат для предупреждения и лечения нарушений, сопровождающихся глазным ангиогенезом и/или повышенной проницаемостью сосудов глаза
UA117506C2 (uk) Фармацевтичний препарат, який містить сполуку піридиламінооцтової кислоти
JP2014506582A5 (https=)
WO2004091610A1 (en) Imidazole derivatives for treatment of allergic and hyperproliferative disorders
JP2018538357A (ja) 化合物
JP2022116328A (ja) 線維症疾患の治療及び/又は予防用アミノナフトキノン化合物
US11576916B2 (en) Methods of preventing or treating ophthalmic diseases
JP2015083565A5 (https=)
JP2014521647A5 (https=)
JP2014521642A5 (https=)
FI3519050T3 (fi) Koostumuksia silmätautien hoitamiseksi
RU2014106364A (ru) Производные n-(имидазолидин-2-илидин)хинолина как модуляторы адренергических рецепторов альфа-2
RU2019100424A (ru) Композиции для лечения и профилактики вазомоторных симптомов
RU2015118985A (ru) Производные имидазопиридина
JP2013521316A5 (https=)